Cargando…
Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors
In today’s global plan to completely eradicate hepatitis C virus (HCV), the essential list of medications used for HCV treatment are direct-acting antivirals (DAAs), as interferon-sparing regimens have become the standard-of-care (SOC) treatment. HCV nonstructural protein 5A (NS5A) inhibitors are a...
Autores principales: | Hamdy, Jehad, Emadeldin, Nouran, Hamed, Mostafa M., Frakolaki, Efseveia, Katsamakas, Sotirios, Vassilaki, Niki, Zoidis, Grigoris, Hirsch, Anna K. H., Abdel-Halim, Mohammad, Abadi, Ashraf H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146377/ https://www.ncbi.nlm.nih.gov/pubmed/35631457 http://dx.doi.org/10.3390/ph15050632 |
Ejemplares similares
-
Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties,
and Conformational Aspects of Core Scaffolds
por: Leila, Alaa R. S., et al.
Publicado: (2019) -
Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors
por: Mousa, Mai H. A., et al.
Publicado: (2021) -
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors
por: Nasr, Tamer, et al.
Publicado: (2022) -
A Novel Cis-Acting RNA Structural Element Embedded in the Core Coding Region of the Hepatitis C Virus Genome Directs Internal Translation Initiation of the Overlapping Core+1 ORF
por: Vassilaki, Niki, et al.
Publicado: (2020) -
Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections
por: Frakolaki, Efseveia, et al.
Publicado: (2019)